Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:58 AM
Ignite Modification Date:
2025-12-25 @ 4:58 AM
NCT ID:
NCT07065318
Eligibility Criteria:
Inclusion Criteria:
* Being diagnosed with interstitial lung disease and being followed up at the Ankara City Hospital Chest Diseases Clinic,
* Being 18 years of age or older,
* Patients who are being followed up with a diagnosis of ILD according to the ATS/ERS 2022 international ILD guideline,
* Being on the lung transplant waiting list according to the International Society for Heart and Lung Transplantation and are being evaluated for listing and are being followed up by the chest diseases department (25-28),
* Being willing to participate in the exercise program regularly and volunteering to participate in the study,
* Patients who have dyspnea levels of 2 and above according to the Modified Medical Research Council dyspnea scale and are able to ambulate,
* Patients who receive long-term oxygen support will be included.
Exclusion Criteria:
* Patients with a history of exertional syncope,
* Patients in acute exacerbation,
* Patients with sarcoidosis,
* Patients with serious comorbidities that may limit exercise (e.g. musculoskeletal, neurological or cardiovascular problems) will not be included.
* Patients with an aortic aneurysm greater than 5.5 cm,
* Patients with cardiovascular impediments to exercise during cardiological evaluations prior to pulmonary rehabilitation
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
64 Years
Study:
NCT07065318
Study Brief:
Protocol Section:
NCT07065318